Shinsuke Sasada
Hiroshima, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 102 publications
Interim Breast MRI for Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Early Breast Cancer.
Journal: European journal of breast health
Published: June 19, 2026
Lactobacillus reuteri lozenges and chemotherapy-induced oral mucositis in breast cancer outpatients: an exploratory randomized controlled trial.
Journal: Scientific reports
Published: May 03, 2026
Prediction of lymphocyte-predominant breast cancer using microRNA expression in cytology specimens.
Journal: Cancer cytopathology
Published: March 21, 2026
Association between an inpatient oral self-care promotion programme and hospital-acquired infections: a propensity score-matched cohort study.
Journal: The Journal of hospital infection
Published: March 17, 2026
Association between an inpatient oral self-care promotion programme and hospital-acquired infections: a propensity score-matched cohort study.
Journal: The Journal of hospital infection
Published: March 17, 2026
Combined ypT0 and ycN0 for Risk Stratification of ypN0 in Clinically Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A Multicenter Cohort Study.
Journal: Clinical breast cancer
Published: February 10, 2026
Annual report of national clinical database-breast cancer registry in 2023: systemic therapy for small breast cancer.
Journal: Breast cancer (Tokyo, Japan)
Published: January 28, 2026
Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study).
Journal: Breast cancer (Tokyo, Japan)
Published: January 27, 2026
Differences of HER2 Status by HercepTest and PATHWAY 4B5 Immunohistochemical Assays in Breast Cancer.
Journal: Anticancer research
Published: November 09, 2025
Safety of radiotherapy in patients undergoing breast reconstruction based on patient-reported outcomes: a multicenter collaborative study.
Journal: Breast cancer (Tokyo, Japan)
Published: September 05, 2025
Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group.
Journal: Breast cancer (Tokyo, Japan)
Published: August 18, 2025
Last Updated: 09/26/2026